EUVIMEDEUVIMED entdecken
Crossref

Triptonide alleviates sepsis‐associated acute lung injury by suppressing the STAT3/HIF‐1α‐mediated aerobic glycolysis in macrophages

Junjie Zhu iD, Zhuoyao Ou iD, Haochen Ma iD, Qiang Huang iD, Linmin Pan iD, Huating Xie iD, Guoquan Pan iD, Shengwei Jin iD

British Journal of Pharmacology · 06.11.2026

DOI: 10.1111/bph.70725 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Pharmacology, online erschienen am 06.11.2026. Verfasst von Junjie Zhu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesia and Critical Care, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhe…. Die Arbeit nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Natural Science Foundation of China Joint Fund Project, Summit Advancement Disciplines of Zhejiang Province (Wenzhou Medical University - Pharmaceutics).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose Sepsis‐associated acute lung injury (SA‐ALI), represents a major contributor to mortality among septic patients during the early hyperinflammatory phase. Triptonide, a diterpenoids extract from Tripterygium wilfordii Hook f has anticancer and contraceptive effects. However, its potential and mechanism in SA‐ALI are largely unknown. This study aims to evaluate the therapeutic efficacy and elucidate underlying mechanisms of triptonide in SA‐ALI to identify new clinical strategies. Experimental Approach Lipopolysaccharide (LPS)‐induced endotoxemia model or caecal ligation and puncture (CLP) model was used to induce SA‐ALI in mice, accompanied by treatment with triptonide, triptolide and 2‐methoxyestradiol. Parallel in vitro experiments involved LPS‐treated mouse primary macrophages cultured with or without triptonide. Transcriptomic sequencing of macrophages was performed to explore the anti‐inflammatory mechanisms of triptonide, which were further substantiated using specific activators, inhibitors and adeno‐associated virus (AAV)‐mediated gene targeting. Key Results Our data shows that triptonide effectively inhibits macrophage pro‐inflammatory activation, reduces pulmonary inflammation and alleviates SA‐ALI pathology (i.e. inflammatory cell infiltration, oedema and cell apoptosis), thereby improving the survival of septic mice. Transcriptomic sequencing combined with metabolic analysis shows that triptonide suppresses aerobic glycolysis in pro‐inflammatory macrophages by inhibiting the Signal Transducer and Activator of Transcription 3 (STAT3)/Hypoxia inducible factor‐1α (HIF‐1α) axis. Notably, the therapeutic efficacy of triptonide against SA‐ALI was abolished in myeloid cell‐specific HIF‐1α overexpressed mice (LyzM‐Cre DIO‐ hif1a mice). Conclusions and Implications Triptonide protects against SA‐ALI by suppressing the STAT3/HIF‐1α signalling axis, thereby inhibiting aerobic glycolysis‐mediated pro‐inflammatory macrophage activation, which suggests that triptonide is a promising therapeutic strategy for SA‐ALI.

Schlagwörter

Stichwörter der Autor:innen

STAT3Triptonideaerobic glycolysisinflammationsepsis‐associated acute lung injury

Autor:innen und Institutionen

  • Department of Anesthesia and Critical Care, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Key Laboratory of Pediatric Anesthesiology, Ministry of Education, Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Precision Anesthesiology Key Laboratory of Zhejiang Province, Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Department of Anesthesiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.

ORCID-Profile: Junjie Zhu, Zhuoyao Ou, Haochen Ma, Qiang Huang, Linmin Pan, Huating Xie, Guoquan Pan, Shengwei Jin

Förderung

  • National Natural Science Foundation of China
  • National Natural Science Foundation of China Joint Fund Project
  • Summit Advancement Disciplines of Zhejiang Province (Wenzhou Medical University - Pharmaceutics)
  • Zhejiang Province's 'Jianbing Leading Goose +X' R & D Plan

Zitieren

APA

Zhu, J., Ou, Z., Ma, H., Huang, Q., Pan, L., Xie, H., Pan, G., & Jin, S. (2026). Triptonide alleviates sepsis‐associated acute lung injury by suppressing the STAT3/HIF‐1α‐mediated aerobic glycolysis in macrophages. British Journal of Pharmacology. https://doi.org/10.1111/bph.70725

Vancouver

Zhu J, Ou Z, Ma H, Huang Q, Pan L, Xie H, et al. Triptonide alleviates sepsis‐associated acute lung injury by suppressing the STAT3/HIF‐1α‐mediated aerobic glycolysis in macrophages. British Journal of Pharmacology. 2026. doi:10.1111/bph.70725

BibTeX
@article{Zhu2026,
  author = {Zhu, Junjie and Ou, Zhuoyao and Ma, Haochen and Huang, Qiang and Pan, Linmin and Xie, Huating and Pan, Guoquan and Jin, Shengwei},
  title = {Triptonide alleviates sepsis‐associated acute lung injury by suppressing the STAT3/HIF‐1α‐mediated aerobic glycolysis in macrophages},
  journal = {British Journal of Pharmacology},
  year = {2026},
  doi = {10.1111/bph.70725}
}
Kostenlos starten →